Eltanexor Effectively Reduces Viability of Glioblastoma and Glioblastoma Stem-Like Cells at Nano-Molar Concentrations and Sensitizes to Radiotherapy and Temozolomide
Current standard adjuvant therapy of glioblastoma multiforme (GBM) using temozolomide (TMZ) frequently fails due to therapy resistance. Thus, novel therapeutic approaches are highly demanded. We tested the therapeutic efficacy of the second-generation XPO1 inhibitor Eltanexor using assays for cell v...
I tiakina i:
Ngā kaituhi matua: | , , , , , , , , , |
---|---|
Hōputu: | Tuhinga |
Reo: | Ingarihi |
I whakaputaina: |
Philipps-Universität Marburg
2022
|
Ngā marau: | |
Urunga tuihono: | Kuputuhi katoa PDF |
Tags: |
Tāpirihia he Tūtohu
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
Publikationen im Open Access gefördert durch die UB